...and today its ours. Kaptivate celebrates its 12th anniversary with a look back to a challenging pandemic year but also a year of growth, new relationships, and new possibilities.
Today’s lesson in the “road to hell is paved with good intentions” focuses on Astra Zeneca. The British-Swiss pharmaceutical firm partnered with the University of Oxford to develop the only no-profit, COVID vaccine aimed at addressing US/Europe’s needs but also that of the developing world. Great ambition needs an equal dose of thoughtful execution.
Award Announcement: Kaptivate helps DOT make the case for smarter, safer roads.
So much has changed in just a few weeks. These rapid-fire changes starkly contrast against years of organizational inaction despite a digital transformation preparing us for this moment.
